Risk factors for ischemic stroke: Dubbo study of the elderly

Stroke

Volumn 29, Issue 7, 1998, Pages 1341-1346

  Simons, Leon A ^a,d   McCallum, John ^b   Friedlander, Yechiel ^c   Simons, Judith ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF WESTERN SYDNEY   (Australia)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d ST VINCENT S HOSPITAL   (Australia)

Author keywords

Elderly; Prospective studies; Risk factors; Stroke, ischemic

Indexed keywords

ADULT; AGED; AGING; ARTICLE; AUSTRALIA; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PEAK EXPIRATORY FLOW; PHYSICAL DISABILITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

EID: 0031837204     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.7.1341     Document Type: Article

References (41)

1. Heart and Stroke Facts Report. Canberra, Australia: National Heart Foundation of Ausiralia; 1996.
2. Simons LA, McCallum J, Friedlander Y, Simons J, Powell I, Heller R. Dubbo Study of the elderly: sociological and cardiovascular risk factors at entry. Aust N Z J Med. 1991;21:701-709.
3. Bennet NE. Hypertension in the elderly. Lancet. 1994;344:447-449.
4. Hebert PR, Gaziano JM, Chan KS, Hennekens CH. Cholesterol lowering with statin drugs, risk of stroke, and total mortality: an overview of randomized trials. JAMA. 1997;278:313-321.
5. Weling L, Svardsudd K, Wilhelmsen L, Larrson B, Tibblin G. Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med. 1987;317:521-526.
6. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-988.
7. Shaper AG, Phillips AN, Pocock SJ, Walker M, MacFarlane PW. Risk factors for stroke in middle aged British men. BMJ. 1991;302:1111-1115.
8. Prospective Studies Collaboration. Cholesterol, diastolic blood pressure and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet. 1995;346:1647-1653.
9. Knuiman MW, Vu HTV. Risk factors for stroke mortality in men and women: the Busselton Study. J Cardiovasc Risk. 1996;3:447-452.
10. Thun MJ, Peto R, Lopez AD, Monaco JH, Henley J, Heath CW, Doll R. Alcohol consumption and mortality among middle-aged and elderly US adults. N Engl J Med. 1997;337:1705-1714.
11. Yano K, Reed DM, MacLean CJ. Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. Stroke. 1989;21:1460-1465.
12. Iso H, Jacobs BR, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989; 320:4-10.
13. Simons LA, McCallum J, Simons J, Powell I, Ruys J, Heller R, Lerba C. The Dubbo Study: an Australian prospective community study of the health of elderly. Aust N Z J Med. 1990;20:783-789.
14. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods. 2nd ed. Geneva, Switzerland: World Health Organization; 1982.
15. Gregg I, Nunn AJ. Peak expiratory flow in normal subjects. BMJ. 1973; 3:282-284.
16. Allain CC, Poon LC, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-475.
17. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19:476-482.
18. Burstein N, Scholnick HR, Morphin R. Rapid methods for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970;11:583-595.
19. Simons L, Friedlander Y, Simons J, McCallum J. Lipoprotein(a) is not associated with coronary heart disease in the elderly: cross-sectional data from the Dubbo Study. Atherosclerosis. 1993;99:87-95.
20. McCallum J, Mackinnon A, Simons LA, Simons J. Measurement properties of the Center for Epidemiological Studies Depression Scale: an Australian community study of aged persons. J Gerontol B Soc Sci. 1995;50B:S182-S189.
21. Commission on Professional and Hospital Activities, National Center for Health Statistics. International Classification of Diseases: Clinical Modification. 9th rev ed. Ann Arbor, Mich: Commission on Professional and Hospital Activities; 1986.
22. United Nations. World Population Prospects 1990. New York, NY: United Nations; 1991.
23. Simons LA, Friedlander Y, McCallum J, Simons J. Risk factors for coronary heart disease in the prospective Dubbo Study of Australian elderly. Atherosclerosis. 1995;117:107-118.
24. Seeman T, Mendes de Leon A, Berkman L, Ostfeld A. Risk factors for coronary heart disease among older men and women: a prospective study of community-dwelling elderly. Am J Epidemiol. 1993;138:1037-1049.
25. Manolio TA, Ettinger WH, Tracy RP, Kuller LH, Borhani NO, Lynch JC, Fried LP. Epidemiology of low cholesterol levels in older adults: the Cardiovascular Health Study. Circulation. 1993;87:728-737.
26. Martin R, Bogousslavsky J. Embolic versus nonembolic causes of ischemic stroke. Cerebrovasc Dis. 1995;5:70-74.
27. Caplan LR. Clinical diagnosis of brain embolism. Cerebrovasc Dis. 1995;5:79-88.
28. Cerebral Embolism Task Force. Cardiogenic brain embolism. Arch Neurol. 1986;43:71-84.
29. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154: 1449-1457.
30. Wilt TJ, Rubins HB, Robins SJ, Riley WA, Collins D, Elam M, Rutan G, Anderson JW. Carotid atherosclerosis in men with low levels of HDL cholesterol. Stroke. 1997;28:1919-1925.
31. Vaughan CJ, Murphy NB, Buckley BM. Statins do more than just lower cholesterol. Lancet. 1996;348:1079-1082.
32. Jousilahti P, Vartiainen E, Tuomilehto J, Puska T. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet. 1996;348:567-572.
33. Simons LA, McCallum J, Simons J, Friedlander Y. Peak expiratory flow, mortality and coronary disease in the Australian elderly. Med J Aust. 1997;166:526-529.
34. Richardson STN, Matthews KB, Cruickshank JK, Geddes AM, Stuart J. Coagulation activity and hyperviscosity in infection. Br J Haematol. 1979;42:469-480.
35. Mendall MA, Carrington D, Strachan D, Patel P, Molineaux N, Levi J, Toosey T, Camm AJ, Northfield TC. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary artery disease. J Infect. 1995;30:121-128.
36. Simons LA, McCallum J, Friedlander Y, Simons J. Predictors of mortality in the prospective Dubbo Study of Australian elderly. Aust N Z J Med. 1996;26:40-48.
37. Simons LA, McCallum J, Friedlander Y, Simons J. Diabetes, mortality and coronary heart disease in the prospective Dubbo Study of Australian elderly. Aust N Z J Med. 1996;26:66-74.
38. Coffey CE, Wilkinson WE, Weiner RD, Parashos IA, Bjang WT, Webb MC, Figiel GS, Spritzer CE. Quantitative cerebral anatomy in depression: a controlled magnetic resonance imaging study. Arch Gen Psychiatry. 1993;50:7-16.
39. Hickie I, Scott E, Mitchell P, Wilhelm K, Austin MP, Bennett B. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry. 1995;37:151-160.
40. Enis J. Stroke prevention in patients with non-valvular atrial fibrillation: a current community perspective. J Clin Neurosci. 1997;4:320-325.
41. Brass LM, Krumholz HM, Scinto JM, Radford M. Warfarin use among patients with atrial fibrillation. Stroke. 1997;28:2382-2389.